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Abstract
Background: In Europe, surveillance and monitoring of pe-
diatric tuberculosis (TB) remains important, particularly in 
the light of migration in recent years. The aim of the study 
was to evaluate incidence rates of childhood TB and detailed 
diagnostic pathways and treatment. Methods: Data were 
collected through the Swiss Pediatric Surveillance Unit 
(SPSU) from December 2013 to November 2019. Monthly 
 notifications are obtained from the 33 pediatric hospitals in 
the SPSU, and a detailed questionnaire was sent out upon 
notification. Inclusion criteria were children and adolescents 
aged up to 15 years with culture- or molecular-confirmed TB 
disease or for whom a treatment with ≥3 antimycobacterial 
drugs had been initiated. Data were compared with age-
matched notification data from the Swiss Federal Office of 
Public Health (FOPH). Results: Of the 172 cases notified to 
SPSU, a detailed questionnaire was returned for 161 (93%) 
children, of which 139 met the inclusion criteria. Reasons for 
exclusion were age >15 years, double reporting, and not ful-
filling the criteria for TB disease. During the same time peri-
od, 172 pediatric TB cases were reported to the FOPH, result-
ing in an incidence of 2.1 per 100,000, ranging from 1.4 to 2.8 
per year, without a clear trend over time. In the 64 (46.0%) 
foreign-born children, incidence rates were higher and 
peaked in 2016, with 13.7 per 100,000 (p = 0.018). The me-
dian interval between arrival in Switzerland and TB diagnosis 
was 5 (IQR 1–21) months, and 80% were diagnosed within 24 
months of arrival. In 58% of the cases, TB disease was con-
firmed by culture or molecular assays. Age >10 years, pres-
ence of fever, or weight loss were independent factors asso-
ciated with confirmed TB. Conclusion: The annual pediatric 
TB incidence rate only varied among foreign-born children 
and was highest in 2016 when refugee influx peaked in Eu-
rope. Importantly, most foreign-born children with TB were 
diagnosed within 2 years after arrival in Switzerland. Thus, 
the early period after arrival in Switzerland is associated with 
a higher risk of TB disease in children, and this should be con-
sidered for screening guidance in refugees.
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Tuberculosis (TB) disease remains a public health 
threat in Europe with an estimated 259,000 cases in the 
World Health Organization European region in 2018 [1]. 
In the same report, children <15 years account for 4% of 
all new and relapse TB cases in Europe, corresponding to 
an annual notification rate of 2.5/100,000.
Incidence rates are generally used to assess the burden 
of TB disease across countries but also across subpopula-
tions. While the overall incidence of TB in Europe is sta-
ble on a low level, in recent years, higher incidence rates 
are observed in specific populations, including refugees 
in studies from Sweden [2], the UK [3], Italy [4], and the 
USA [5]. The rate of TB disease in children thereby serves 
as a sentinel for ongoing transmission of Mycobacterium 
tuberculosis as progression to TB disease in children oc-
curs mostly within a short period of time after infection 
[6].
Migration has and continues to influence TB inci-
dence in host countries worldwide [7, 8]. Refugees and 
asylum seekers have a higher risk for certain infectious 
diseases, including gastrointestinal infections, malaria, 
and TB [9, 10]. Contributing factors for this increased risk 
are mainly the higher incidence of the disease in their 
country of origin and factors related to conditions during 
migration such as overcrowding, low hygiene standards, 
and malnutrition [11, 12].
Studies analyzing the impact of the most recent refu-
gee crises on TB in Europe showed that up to 14% of un-
accompanied minor refugees had TB infection when 
screened in Germany [13] and Sweden in 2015 [14]. A 
Swiss study in newly arrived migrant children shows 7% 
of screened children had TB infection or TB disease, and 
an association with origin from a country with moderate 
to high TB incidence, older age, and contact to a TB index 
case was found [15]. However, detailed data on incidence 
rates, associated risk factors, and clinical characteristics 
in children with TB after migration to Europe are impor-
tant and lacking in most national and regional reports 
[16, 17].
The aim of this study was to describe the incidence of 
TB disease in children notified to the Swiss Pediatric Sur-
veillance Unit (SPSU) and the Swiss Federal Office of 
Public Health (FOPH) during the years of high refugee 
arrivals. Further to this, we aimed to characterize epide-
miological factors, focusing on the origin and history of 
migration and analyze details of diagnostic pathways and 
treatment of TB in children.
Methods
Study Design and Population
Pediatric TB disease was actively monitored in a cross-sec-
tional observational study as part of the SPSU from December 
2013 to November 2019. All 33 national pediatric hospitals in 
Switzerland participated in the SPSU and notified the studied 
diseases in a monthly report (www.spsu.ch). Upon notification, 
a questionnaire was sent to the notifying hospital to obtain de-
tailed clinical data (see online suppl. material; for all online sup-
pl. material, see www.karger.com/doi/10.1159/000517029) by 
the local investigator. TB disease cases are also captured by the 
FOPH as TB is a mandatory notifiable disease. To ensure com-
parability between the 2 notification systems, we used the same 
case definition for the SPSU study as were in place for the FOPH 
notifications. A TB case was defined as the detection of M. tu-
berculosis, M. africanum, M. bovis, M. caprae, or “Mycobacteri-
um complex” by culture or molecular assays or when a treatment 
with ≥3 antimycobacterial drugs was initiated. For the analysis 
of the pediatric cases, only individuals up to 15 years were in-
cluded.
Collected Variables
The SPSU questionnaire (online suppl. material) included de-
mographic characteristics such as age, sex, and country of birth of 
the child and parents, risk factors indicating exposure to an index 
case, clinical and radiologic findings, results of immunological, 
culture, and molecular diagnostics, and treatment parameters.
BCG vaccination status was assessed based on written docu-
mentation, characteristic scar, or history. Chest radiography find-
ings and the use of further imaging including sonography, com-
puted tomography (CT), and magnetic resonance imaging were 
recorded.
Results of the tuberculin skin test (TST), T-SPOT.TB, and 
QuantiFERON-TB (QFT) tests were recorded as positive, nega-
tive, and borderline/indeterminate, and if available, with details of 
the diameter of induration, count of positive spots, and concentra-
tions of interferon-γ. The following cutoffs determined a positive 
TST or interferon gamma release assay according to Swiss nation-
al recommendations and manufacturers’ instructions [18]: a TST 
diameter of induration >5 mm, T-SPOT.TB number of spots in the 
TB antigen tubes ≥5 spots, and QFT interferon-γ concentration in 
the TB antigen tubes ≥0.35 IU.
Results of drug sensitivity testing were collected from culture 
or molecular-confirmed cases. Doses of all antimycobacterial and 
other drugs were recorded. From the variables notified to the 
FOPH, the following were used in this study: demographic char-
acteristics including age and sex and data from culture or molecu-
lar confirmation of TB diagnosis.
Definitions
For the SPSU and FOPH data set, we used 1-year periods, 
which lasted each from December to the following November and 
matched them to the population data for the following calendar 
year. The time point of study inclusion was defined by the month 
of notification for the SPSU data and by the month of diagnosis 
for the date from the FOPH. For the assessment of clinical and 
diagnostic findings, the study population was divided into 4 age-
groups from 0 to <2, 2 to <5, 5 to <10, and 10 to 15 years of age 
[19].
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The population-based incidence was calculated using popula-
tion data for individuals living in Switzerland aged up to 15 years 
provided by the Swiss Federal Statistical Office. Comparisons be-
tween Swiss-born and foreign-born children were done using the 
χ2 or Fisher exact test for categorical and the Wilcoxon rank sum 
test for non-normal distributed continuous variables. For the time 
since arrival in Switzerland in foreign-born children, the Kaplan-
Meier estimate was used, and differences between groups were as-
sessed with the log-rank test. The significance of the peak inci-
dence among foreign-born children was assessed with a permuta-
tion test. Confidence intervals of incidence rates were calculated 
using exact Poisson distribution.
To identify clinical characteristics associated with culture and/
or molecular confirmation, univariable and multivariable logistic 
regression was done. A multivariable logistic regression model was 
fitted by including the variables origin and sex a priori and back-
ward selection. A p value of <0.05 was considered as potentially 
significant. Statistical analyses were done using R (version 4.0.0)/R 
Studio (version 1.3.1073).
Ethics
The study was approved by the local Ethics Committee in 




Of the 172 cases notified to the SPSU, a detailed ques-
tionnaire was returned for 161 children with TB disease 
(94%), and 139 were included in the final analysis. Rea-
sons for exclusion were age >15 years (n = 12), double 
reporting (n = 8), and latent TB infection (n = 2). In com-
parison, 172 pediatric cases were notified to the FOPH in 
the same observational period, and these accounted for 
5% of all notified TB disease cases in Switzerland. In chil-
dren with TB disease notified to the SPSU, the median age 
was 6.7 (interquartile range [IQR] 2.6–13.8) years, and 58 
(42%) children were <5 years of age. The median age of 
children notified to the FOPH was 8.0 (IQR 2.0–14.0), 
with 62 (36%) children <5 years of age (Table 1). In the 
SPSU data set, 72 children (52%) were Swiss-born, 64 
(46%) were foreign-born, and for 3 (2%) children, the 
country of birth was unknown (Fig.  1). Foreign-born 
children were from Eritrea (16%), Somalia (9%), and Af-
ghanistan, Brazil, and Sudan (2% each). The median age 
of Swiss-born children was 3.1 years (IQR 2.0–7.6) and of 
foreign-born children 13.7 years (IQR 8.8–15.0) (p < 
0.001). An index case as the source of infection was stated 
in 89 (64.0%) children, and transmission occurred in 
72/89 (81%) children in the same household (online sup-
pl. Table 1).
Population-Based Incidence
The overall incidence of TB disease in the SPSU and 
FOPH data set was 1.7/100,000 and 2.1/100,000, respec-
tively. Overall incidence rates increased at the begin-
ning of the observational period and peaked in 2016 at 
2.2 (SPSU) and 2.8 (FOPH)/100,000 children in 2016 
(Fig.  2). Incidence rates among Swiss-born children 
were consistently low during the observational period 
(0.4–1.3/100,000 children), while those of foreign-born 
children reached a significant peak in 2016 (p = 0.018) 
Table 1. Baseline characteristics form cases notified to the SPSU and FOPH
SPSU, all SPSU, Swiss-born SPSU, foreign-born p value* FOPH
N 139 72 64 172
Age median (IQR), year 6.7 (2.6–13.8) 3.1 (2.0–7.6) 13.7 (8.8–15.0) <0.001 8.0 (2.0–14.0)
<5 years of age, n (%) 58 (40) 46 (63.9) 10 (15.6) <0.001 62 (36)
Male, n (%) 75 (54) 36 (50.0) 39 (60.9) 0.229 97 (56)
Culture or molecular confirmation in age-groups, n (%)
Overall 80 (58) 38 (53) 40 (63) 0.330 106 (62)
0 to <2 years 11 (48) 8 (44) 2 (50) 17 (63)
2 to <5 years 13 (37) 13 (46) 0 (0) 17 (49)
5 to <10 years 13 (57) 8 (62) 4 (44) 17 (59)
>10 years 43 (74) 9 (69) 34 (76) 55 (68)
Index case known, n (%) 89 (64) 57 (79) 29 (45) <0.0001 –
Asymptomatic, n (%) 44 (32) 30 (42) 12 (19) 0.007 –
BCG vaccinated (written proof or scar), n (%) 19 (20) 2 (3) 17 (57) <0.001 –
SPSU, Swiss Pediatric Surveillance Unit; FOPH, Swiss Federal Office of Public Health; IQR, interquartile range. Statistically significant p values are in 














0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
■ Child: foreign-born
■ Child: Swiss-born, parents: foreign-born
■ Child: Swiss-born, parents: swiss-born
■ Child: Swiss-born, parents: country of birth unknown
■ Child: country of birth unknown
Fig. 1. Number of cases per age-group in all 
cases notified to the SPSU over the obser-
vational period stratified by country of 
birth of the children and their parents. 




















2014 2015 2016 2017 2018 2019
1.22 1.66 2.17 2.15 1.17 1.96
1.40 2.30 2.80 2.40 2.10 1.80
0.76 1.26 0.84 1.32 0.40 1.38





Fig. 2. Incidence of TB disease cases noti-
fied to the SPSU and FOPH over the obser-
vational period from 2014 to 2019. Inci-
dence rate of foreign-born children were 
significantly higher than that in Swiss-born 
children and reached a maximum in 2016. 
SPSU, Swiss Pediatric Surveillance Unit; 
FOPH, Swiss Federal Office of Public 
Health; TB, tuberculosis.
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and were consistently >1 magnitude higher 
(5.313.7/100,000 children, all p values <0.01). Children 
aged 5 to <10 years had the lowest incidence rate in both 
data sets (Table 2).
For the 67 foreign-born children, the time since ar-
rival in Switzerland was recorded in 62 (93%) cases. The 
median time from arrival to TB diagnosis was 5 (IQR 
1–21) months. By 6 months, 54% of the children were 
diagnosed, and by 24 months, 80% of the children were 
diagnosed (Fig. 3). The longest time interval of TB di-
agnosis since arrival was 12 years, reported for 3 chil-
dren; for 1 child, an exposure in the same household 
was stated, and for the other 2 the source of infection 
was unknown. The time interval between arrival in 
Switzerland to TB diagnosis was similar between age-
groups (<5, 5 to <10, and >10 years, p = 0.4) and similar 
in those with and without symptoms (p = 0.5), who 
were screened for TB upon arrival or investigated as 
part of contact tracing.
Forms of TB and Clinical Presentation
Detailed data on clinical presentation and risk factors 
were only available in the SPSU data set. A total of 118 
children (85%) had pulmonary TB. Of the 20 (14%) chil-
dren with extrapulmonary TB, the following affected ar-
eas were stated as follows: in 6 children, lymph node; in 
5, pleural; in 3, central nervous system; in 3, abdominal; 
in 2 cases, a miliary form without further specification; 
and missing information in 1 case. In the 95 (68%) chil-
dren with symptoms, the following were most common: 
cough in 63 (45%), fever in 45 (32%), weight loss in 44 
(32%), and wheezing in 5 (4%) children. Cough was re-
ported to be present for a median time of 28 (IQR 14–40) 
and fever with a median time of 12 (IQR 5–21) days.
Age-group SPSU FOPH
<2 years 2.23 (95% CI 1.41–3.34) 2.61 (95% CI 1.72–3.80)
2 to <5 years 2.26 (95% CI 1.57–3.14) 2.26 (95% CI 1.57–3.14)
5 to <10 years 0.91 (95% CI 0.58–1.36) 1.15 (95% CI 0.77–1.65)
10 to <16 years 1.97 (95% CI 1.49–2.54) 2.75 (95% CI 2.18–3.42)
SPSU, Swiss Pediatric Surveillance Unit; FOPH, Swiss Federal Office of Public Health; 
TB, tuberculosis.





































Fig. 3. Time analysis of foreign-born children displaying probability of TB disease diagnosis by time since ar-





The Use and Results of Diagnostic Tests
In the SPSU data set, diagnosis was confirmed by cul-
ture or molecular techniques in 80 (58%) children (Ta-
ble  1). Of those, 73 (52%) were positive by culture, 49 
(35%) by molecular assay, and 42 (30%) by both methods. 
In 7 children, diagnosis was confirmed by molecular as-
say only, while culture remained negative, and in 34 chil-
dren, diagnosis was confirmed by culture only, while mo-
lecular assay remained negative. The rate of confirmed 
TB was highest in children aged >10 years with 74.1%. In 
the younger age-group, confirmation of TB was reported 
as follows: 5 to <10 years, 57%; 0 to <2 years, 48%; and 2 
to <5 years, 37%. The rate of confirmation was compa-
rable in foreign-born (63%) and Swiss-born children 
(53%, p = 0.33). Characteristics that were associated with 
TB confirmation in the univariable logistic regression 
were age, presence of fever, weight loss, and symptom-
atic presentation (Table 3). In a multivariable model, the 
age-group of children >10 years, the presence of fever, 
and the presence of weight loss remained independently 
associated with TB confirmation (Table 3).
Information on resistance testing from culture or mo-
lecular-confirmed cases was available in 68 (85%) cases, 
of which 4 were isoniazid (two M. bovis infections, one M. 
tuberculosis, and one unknown isolate) and 3 isolates 
were pyrazinamide resistant, 2 of which were M. bovis 
infections. No multidrug resistant cases were reported.
Immuno-diagnostic test results were only available 
from the SPSU data set. The TST was done in 82 (59%), 
T-SPOT.TB in 22 (16%), and the QFT in 79 (57%) cases 
and reported to be positive in 58 (71), 15 (68), and 60 
(76%) cases, respectively. In 7 children, the QFT showed 
an indeterminate result.
Chest radiography was performed for 135 (97.1%) 
children and a chest CT scan in 52 (37.4%). Neuroimag-
ing with CT scan or magnetic resonance imaging was 
done in 10 (7.2%) children. Ultrasound was performed in 
32 (23%) children, mostly for abdominal imaging (in 22, 
69%).
On chest radiography, hilar lymphadenopathy and 
consolidation were the most frequently found abnormal-
ities. Bronchial compression was found more frequently 
in children <2 years, calcified lymph nodes more fre-
quently in children 5 to <10 years, and effusion and cav-
erns more frequently in the children >10 years old (Fig. 4).
A total of 78 children (56%) were tested for HIV infec-
tion, all of which were negative. Swiss-born children were 
significantly less often tested (in 28 cases, 39%) than for-
eign-born children (in 43 cases, 82%; p value <0.0001).
Choice and Dosing of Antituberculous Medication
Details on treatment were only available in the SPSU 
data set. Overall, 69 (49.6%) children received a triple 
(isoniazid, rifampicin, and pyrazinamide) and 53 (37.4%) 
Table 3. Univariable and multivariable logistic regression analysis for factors associated with culture or molecular 
confirmation of TB disease
Univariable log regression Multivariable log regression
OR 95% CI p value OR 95% CI p value
Age 0 to <2 years Reference Reference
Age 2 to <5 years 0.74 0.25–2.2 0.592 0.78 0.24–2.61 0.688
Age 5 to <10 years 1.44 0.44–4.81 0.547 1.37 0.36–5.35 0.643
Age >10 years 3.78 1.35–11.06 0.013 4.40 1.23–17.32 0.023
Gender (male) 1.07 0.53–2.14 0.847 1.22 0.54–2.78 0.629
Origin (Swiss-born) 0.61 0.30–1.23 0.172 2.20 0.84–6.26 0.121
Asymptomatic 0.21 0.09–0.45 <0.0001 – – –
Cough 1.63 0.81–3.31 0.172 – – –
Fever 3.53 1.60–8.35 <0.003 3.98 1.65–10.33 0.003
Weight loss 5.98 2.52–15.66 <0.001 4.19 1.51–12.84 0.008
The variable of presentation with or without symptoms was composed of variable reporting symptoms and 
was assessed only in the univariable models. For fitting the multivariable model, only variables of symptoms with 
sufficient observations were evaluated, and after backward selection, only fever and cough remained included. 
The grouped variable of presentation with or without symptoms was only assessed in the univariable model and 
not included in the multivariable model. Instead in multivariable model, the variables cough, fever, and weight 
loss were included, and variables for other symptoms were excluded for low number of recorded observations. 
Statistically significant p values are in bold. TB, tuberculosis; OR, odds ratio; CI, confidence interval.
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a quadruple treatment (with the addition of ethambutol). 
The range of drug dosages prescribed was highly corre-
lated with the national guidelines; some children received 
fixed dose combinations (online suppl. Fig. 1).
Discussion
Since our last detailed analysis of childhood TB notifi-
cations in Switzerland for the years 1996–2011, this is the 
first analysis including a period of high migrant arrivals 
in Switzerland [20]. The current overall annual TB inci-
dence rates of 1.7–2.1/100,000 children in the years 2014–
2019 are slightly higher than those in the earlier time pe-
riod, which was 1.6/100,000 children. Of particular inter-
est is the considerable increase of the TB incidence rate in 
2016 and the higher incidence in foreign-born children. 
This has been highly likely influenced by the large mi-
grant arrival of refugees and asylum-seeking children in 
all European countries in 2015 and 2016. Similar to our 
findings, higher TB incidence rates among foreign-born 
than those in native-born children were observed in oth-
er European countries, like Sweden [21], the Netherlands 
[22], and the UK [3]. Similarly, a prospective study in the 
region of Campania in Italy also observed increasing TB 
incidence rates among children over an observational pe-
riod from 2009 to 2018 [23]. The authors of that study 
observed a correlation between TB incidence and the rate 
of migrants living in the region, suggesting that the dis-
ease occurrence was highly likely influenced by the influx 
of migrants.
Time to Diagnosis since Arrival
We found that two-thirds of the cases in foreign-born 
children are diagnosed within 1 year of arrival in Switzer-
land. The finding that TB disease in refugees and asylum 
seekers manifests early after arrival in the host country 
has been described in other countries. For example, stud-
ies from the Netherlands and Israel found that 53–58% of 
migrant children developed TB disease within the first 
year after arrival [24, 25]. A further study in the USA 
showed that time from arrival to TB diagnosis was highly 
variable and influenced by the country of origin [5]. A 
shorter time to TB diagnosis with a mean of 1.2 years was 
seen for children originating from China, Burma, and 
Ethiopia, whereas as longer intervals with a mean of 4.5 
years were seen for children originating from Mexico [5].
A large proportion of foreign-born children originated 
from non-European countries and therefore had long mi-
gration routes. Factors related to the migration, like over-
crowding and malnutrition, are assumed to contribute to 
the higher risk of TB disease in the initial period after ar-
rival [26]. In addition, these factors could also contribute 
to the progression to TB disease in children with previ-
ously acquired TB infection. For children who develop 
TB years after arrival in the host country, it remains un-
clear if they are newly infected in the host country or have 
taken longer to progress to TB disease. Our study indi-
cates that foreign-born children are at particular risk ear-
ly after arrival, which should be considered for early 
screening guidance. The fact that a third of foreign-born 
children had TB diagnosed >1 year after arrival under-












































































































and asylum-seeking children. Screening for TB in mi-
grants remains therefore important, and cost effectivity 
has been shown in our setting [27, 28].
Culture Confirmation
In our study, the ratio of children with culture or mo-
lecular confirmation of TB was approximately 60%. This 
is higher, than what we have found in our previous anal-
ysis and also what is commonly reported in other Euro-
pean countries, where culture confirmation reaches ap-
proximately 50% [20, 29]. In addition, in a high-burden 
TB setting, culture confirmation is even lower with a me-
dian proportion of 29% as shown by a meta-analysis [30]. 
We found that age, presence of fever, and weight loss were 
independently associated with culture and/or molecular 
confirmation. A recently published study from the UK 
showed that older, female, foreign-born children, and 
those with pulmonary disease are more likely to be cul-
ture or molecular confirmed [3]. Similarly, in our study, 
children aged >10 years were more likely to be culture or 
molecular confirmed, whereas no effect of sex and coun-
try of origin was observed in both univariable and multi-
variable models. Weight loss is a symptom commonly 
seen late in the TB disease course; therefore, it seems rea-
sonable that we observed an association with culture or 
molecular confirmation. In contrast, the finding that the 
presence of fever is associated with culture or molecular 
confirmation was somehow surprising as it is assumed to 
appear rather early in disease course, when TB might still 
be paucibacillary, and we would not expect confirmation 
of the diagnosis [31, 32].
Radiologic Imaging
Radiologic imaging with chest radiography is a stan-
dard investigation when pulmonary TB is suspected [33, 
34]. Hilar lymphadenopathy and consolidation were 
most frequently observed in all age-groups [35]. Despite 
the small number of included children, bronchial com-
pression was most observed in children aged <2 years, 
which is a typical finding in this age-group known from 
the prechemotherapy era [6]. Caverns and effusion are 
characteristics of adult-type TB and were also most often 
observed in the oldest age-group in our study. In contrast 
to studies from the prechemotherapy era, in which cav-
erns were mostly observed in children older than 10 years, 
we also observed caverns in younger children [6]. The 
significance of caverns in younger children is less clearly 
understood; several case series have described caverns in 
younger children, and it was suggested that distinct 
pathophysiological mechanisms such as bronchial ob-
struction and liquification of primary focus contribute to 
the development of caverns in this age-group [36].
CT is recommended for the diagnosis of TB in chil-
dren with inconclusive clinical presentation and diagnos-
tics or to search for local complications. The use of CT 
imaging in about 40% of cases in our study was remark-
able, but in a comparable range to an Italian study of >500 
children with active TB from 2010 to 2012, CT was also 
used in a high proportion of 56% [4]. Despite not having 
collected detailed data on the indications for CT, we as-
sume that in most cases, it was used to rule out an alterna-
tive diagnosis and local complications. CT is indicated in 
specific circumstances, but its indication should be care-
fully evaluated as it affords an exposure to radiation, ap-
plication of contrast, and sedation in young children. Al-
ternative imaging methods, like sonography, where ra-
diation could be avoided, should be also strengthened in 
the evaluation of pulmonary TB.
Limitations
Our study has several limitations. The observed an-
nual incidence rates were consistently lower in the SPSU 
than those in the FOPH notification data, suggesting that 
the mandatory system routinely captures more cases. A 
direct patient-to-patient comparison of the children in 
the 2 data sets was not possible, which prevents an estima-
tion of the notification rate by a capture-recapture meth-
od. The observational character of our study and the re-
striction to children with TB disease prevents an analysis 
of risk factors for progression of the disease. Despite hav-
ing collected detailed data on treatment, our study did not 
systematically include adverse effects of treatment, chang-
es in treatment regimen, and outcome measurement, 
such as completion of treatment or TB relapse rates. 
However, none of the children were notified to have been 
treated for TB before inclusion in this study.
Conclusion
The complementary character of the 2 notification 
systems used in the study enables further insights of TB 
epidemiology in children. The study shows that annual 
TB incidence rates varied significantly between foreign-
born and Swiss-born children and were timely related to 
the years with high refugee arrival. In particular, the ear-
ly period after arrival in Switzerland is associated with a 
higher risk of TB disease in children, and this should be 
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considered for screening guidance in refugees. Continu-
ous monitoring of incidence rates in children and refu-
gees are important and may help to identify early trends 
of TB epidemiology in the general population.
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